The field of molecular imaging has recently seen rapid advances in the development of
novel contrast agents and the implementation of insightful approaches to monitor biological …

The development of mesenchymal stem cells (MSCs) as cell-based drug delivery vectors for
numerous clinical indications, including cancer, has significant promise. However, a …

A promising new direction for contrast-enhanced magnetic resonance (MR) imaging
involves tracking the migration and biodistribution of superparamagnetic iron oxide (SPIO)-labeled …

Cerenkov luminescence (CL) has been used recently in a plethora of medical applications
like imaging and therapy with clinically relevant medical isotopes. The range of medical …

Purpose: In the proper context, radiotherapy can promote antitumor immunity. It is unknown
if elective nodal irradiation (ENI), a strategy that irradiates tumor-associated draining lymph …

Contrast agents are increasingly being used in diagnostic magnetic resonance (MR) imaging
to help detect and characterize pathological abnormalities. In fact, it has been estimated …

The invasion status of tumour-draining lymph nodes (LNs) is a critical indicator of cancer
stage and is important for treatment planning. Clinicians currently use planar scintigraphy and …

In the era of personalized medicine, there is an urgent need for in vivo techniques able to
sensitively detect and quantify molecular activities. Sensitive imaging of gamma rays is widely …

The aim of this study was to determine the feasibility of Cerenkov luminescence (CL) imaging
of patients undergoing diagnostic 18 F-FDG scans to detect nodal disease. Methods: …

Sclerostin has traditionally been thought of as a local inhibitor of bone acquisition that
antagonizes the profound osteoanabolic capacity of activated Wnt/β-catenin signaling, but serum …